Boston Scientific announces cardiac devices' debut in Europe

02/28/2008 | Boston Globe (tiered subscription model), The

Boston Scientific Corp. announced Thursday that doctors have started to use its implantable Cognis cardiac resynchronization therapy defibrillator and its Teligen implantable cardioverter defibrillator for the treatment of cardiac failure and sudden cardiac arrest in European patients.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC